#37 - Colin Weller, VP & GM Evidence Platform at Medable

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/77/04/57/77045741-1029-cdbc-c0e3-f2b9799011b6/mza_3782441356470718433.jpg/600x600bb.jpg

BioBreakthroughs

Slice of Healthcare LLC

49 episodes

2 months ago

Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.

All content for BioBreakthroughs is the property of Slice of Healthcare LLC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

#37 - Colin Weller, VP & GM Evidence Platform at Medable

BioBreakthroughs

16 minutes

1 year ago

#37 - Colin Weller, VP & GM Evidence Platform at Medable

Join us on the latest episode! Our Guest: Colin Weller, VP & GM of Evidence Platform at Medable.

What you'll get out of this episode:

Introduction of Colin Weller: Vice President and GM of Evidence Platform at Medable, Colin Weller discusses his role in advancing clinical research technology to streamline drug approvals.
Challenges in Drug Development: Weller details the stagnant pace of drug development, highlighting the industry's need for innovation to improve efficiency and reduce costs.
Medable's Ambitious Goals: Aiming to increase the number of drugs approved annually by tenfold through advanced SAS technology and AI, setting a new industry standard.
Innovations in Clinical Trials: Medable has already cut study startup times by 50%, utilizing AI and automation to overhaul traditional processes.
Future of Digital Clinical Trials: Weller predicts significant advancements in decentralized and digital trials, enhancing patient accessibility and data quality.

To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/colin-weller-294ab58/
Company LinkedIn: https://www.linkedin.com/company/medable-inc-/
Website: https://www.medable.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/